Vice Chairman of the Yuhang District Political Consultative Conference, Fu Lihua, and other leaders visited Xingyue Biology for guidance

On July 5, 2022, Fu Lihua, Vice Chairman of the Yuhang District Political Consultative Conference, and He Jianfu, Deputy Director of the Cultural and Historical Committee of the Yuhang District Political Consultative Conference, visited the company for research and guidance, accompanied by Dr. Zhao Hongshi, Deputy General Manager of the company.

Chairman Fu and his delegation first visited the Xingyue R&D Center. Dr. Zhao Hongshi, the Vice General Manager of the company, introduced the hardware facility construction and team building situation of the R&D Center, and then the two sides had a discussion and exchange.

At the symposium, Dr. Zhao Hongshi reported to Chairman Fu on the background of the biopharmaceutical industry, the company's development history, technological research and innovation achievements, talent cultivation, as well as the performance, application areas, and market prospects of the company's products. Dr. Zhao Hongshi stated that Xingyue Biotechnology has achieved technological innovation and industrial chain synergy. On the one hand, the team actively explores independent innovation of silk materials in the field of medical devices; On the other hand, the combination of technology and industry has achieved the landing and transformation of technological innovation achievements. The Xingyue Biotechnology team has achieved the transformation of "silk materials" into "new medical materials" that can be used for treating and saving lives, and has obtained two main documents for medical silk raw materials. Due to its excellent biocompatibility and processability, silk materials can not only be used in the field of high-end medical devices, but also have a wide range of applications in skincare, food, high-performance coatings, and other areas. Xingyue Biotechnology focuses on the development of silk medical raw materials and high-end medical equipment products, gradually replacing imported foreign products, and striving to make medical silk materials the benchmark for high-end biomaterials in China.

After listening to the report, Chairman Fu Lihua highly appreciated and affirmed the innovative achievements of Xingyue Biotechnology in the field of biomaterials. Xingyue Biotechnology adheres to independent research and development, and is committed to innovating the application of traditional silk in the field of medical devices. It has strong core competitiveness, broad application prospects, and good development momentum. I hope the company will continue to strengthen the exploration and research of cutting-edge science, pay more attention to the transformation of scientific research results, closely link technological innovation with market demand, and promote the growth and strength of traditional material silk in the field of life and health; At the same time, we hope that Xingyue Biotechnology will adhere to the development concept of "everything for human health", continue to increase investment in product research and development and technological innovation, create a more complete and rich product system, gradually achieve the substitution of imported materials and products, and actively help the country achieve the strategy of strengthening the country with materials.